Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
19,580 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00378638 | Dose-Dense Chemotherapy Plus Bevacizumab in High Risk Lymph Node Positive Breast Cancer: A Pilot Study | unknown | Phase 2 | 30 | Chap, Linnea I., M.D.INDIV | 1 | Oct 24, 2007 | clinicaltrials |
| NCT00337545 | Phase II Trial of RAD001 in Refractory Colorectal Cancer | completed | Phase 2 | 22 | Swedish Medical CenterOTHER | 1 | Oct 10, 2007 | clinicaltrials |
| NCT00062894 |
| Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 Tositumomab |
| completed |
| Phase 1 / Phase 2 |
| 12 |
| GlaxoSmithKlineINDUSTRY |
| 1 |
| Sep 17, 2007 |
| clinicaltrials |
| NCT00191373 | A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 12, 2007 | clinicaltrials |
| NCT00081315 | Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer | completed | Phase 2 | 130 | MedImmune LLCINDUSTRY | 1 | Aug 21, 2007 | clinicaltrials |
| NCT00061672 | Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma | completed | Phase 2 | 67 | AbbottINDUSTRY | 1 | Aug 15, 2007 | clinicaltrials |
| NCT00073125 | Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma | completed | Phase 2 | 103 | AbbottINDUSTRY | 2 | Aug 15, 2007 | clinicaltrials |
| NCT00061646 | Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 2 | 25 | AbbottINDUSTRY | 1 | Aug 14, 2007 | clinicaltrials |
| NCT00190918 | A Trial for Patients With Gestational Trophoblastic Disease | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 9, 2007 | clinicaltrials |
| NCT00225550 | A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors | terminated | Phase 1 / Phase 2 | — | Adherex Technologies, Inc.INDUSTRY | 1 | Aug 6, 2007 | clinicaltrials |
| NCT00264433 | A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent | completed | Phase 2 | — | Adherex Technologies, Inc.INDUSTRY | 2 | Aug 6, 2007 | clinicaltrials |
| NCT00195078 | Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 29 | Weill Medical College of Cornell UniversityOTHER | 1 | Jul 20, 2007 | clinicaltrials |
| NCT00070837 | MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer | completed | Phase 1 / Phase 2 | 46 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 13, 2007 | clinicaltrials |
| NCT00344851 | Exenatide and Metformin Therapy in Overweight Women With PCOS | completed | Phase 2 | 60 | Metabolic Center of Louisiana Research FoundationOTHER | 1 | Jul 11, 2007 | clinicaltrials |
| NCT00232726 | Clinical Study of Previously Untreated Patients With Malignant Melanoma | completed | Phase 2 | 42 | Clavis PharmaINDUSTRY | 3 | Jul 10, 2007 | clinicaltrials |
| NCT00038714 | A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis | completed | Phase 2 | 27 | Nventa Biopharmaceuticals CorporationINDUSTRY | 1 | Jun 27, 2007 | clinicaltrials |
| NCT00295100 | Tamoxifen-MRI Study | completed | Phase 2 | 78 | University of PennsylvaniaOTHER | 2 | Jun 21, 2007 | clinicaltrials |
| NCT00080080 | Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | — | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00083239 | Study of Talabostat in Advanced Melanoma | completed | Phase 2 | — | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00083252 | Study of Talabostat and Cisplatin in Advanced Melanoma | completed | Phase 2 | — | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00116389 | Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas | terminated | Phase 2 | 60 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00394628 | AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme | unknown | Phase 1 / Phase 2 | 60 | NovaceaINDUSTRY | 1 | May 30, 2007 | clinicaltrials |
| NCT00086034 | Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma | completed | Phase 2 | 35 | Pharmacyclics LLC.INDUSTRY | 1 | May 15, 2007 | clinicaltrials |
| NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | unknown | Phase 2 | 80 | Seattle Cancer Treatment and Wellness CenterOTHER | 1 | May 8, 2007 | clinicaltrials |
| NCT00054886 | Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer | completed | Phase 2 | 63 | PfizerINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00066885 | Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 80 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00109356 | Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia | unknown | Phase 1 / Phase 2 | 55 | NovaceaINDUSTRY | 1 | May 7, 2007 | clinicaltrials |
| NCT00034827 | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer | completed | Phase 2 | 172 | PfizerINDUSTRY | 1 | May 4, 2007 | clinicaltrials |
| NCT00051051 | A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer | completed | Phase 2 | 168 | PfizerINDUSTRY | 9 | May 4, 2007 | clinicaltrials |
| NCT00105092 | Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. | completed | Phase 2 | 50 | Eli Lilly and CompanyINDUSTRY | 1 | May 1, 2007 | clinicaltrials |
| NCT00143884 | Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood | terminated | Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 23, 2007 | clinicaltrials |
| NCT00225056 | Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma | terminated | Phase 2 | 43 | Oncology Specialties, AlabamaOTHER | 1 | Apr 20, 2007 | clinicaltrials |
| NCT00106262 | Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer | terminated | Phase 2 | 38 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Apr 18, 2007 | clinicaltrials |
| NCT00089596 | Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers | completed | Phase 1 / Phase 2 | 10 | ViaCellINDUSTRY | 1 | Apr 12, 2007 | clinicaltrials |
| NCT00083785 | Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases | completed | Phase 2 | 25 | Light Sciences LLCINDUSTRY | 1 | Apr 11, 2007 | clinicaltrials |
| NCT00457808 | Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM | completed | Phase 2 | 25 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Apr 9, 2007 | clinicaltrials |
| NCT00316433 | Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer | terminated | Phase 2 | 24 | Swedish Medical CenterOTHER | 1 | Apr 5, 2007 | clinicaltrials |
| NCT00251329 | Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery | unknown | Phase 2 | 48 | Cancer Research NetworkOTHER | 1 | Apr 4, 2007 | clinicaltrials |
| NCT00076609 | Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 31 | PhytoCeuticaINDUSTRY | 2 | Mar 28, 2007 | clinicaltrials |
| NCT00116909 | A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy | completed | Phase 2 | 85 | OSI PharmaceuticalsINDUSTRY | 1 | Mar 14, 2007 | clinicaltrials |
| NCT00134186 | Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer | completed | Phase 2 | 43 | Pharmacyclics LLC.INDUSTRY | 1 | Mar 5, 2007 | clinicaltrials |
| NCT00114920 | Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults | completed | Phase 2 | 88 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00116662 | An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects | completed | Phase 2 | 84 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00116675 | Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects | completed | Phase 2 | 84 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00117871 | Study With a Topical Gel to Treat Common Warts in Adults | completed | Phase 2 | 48 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00117923 | Study With a Topical Gel to Treat Common Warts in Adults | completed | Phase 2 | 88 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Feb 19, 2007 | clinicaltrials |
| NCT00273884 | Amonafide in Combination With Cytarabine in Secondary AML | completed | Phase 2 | 80 | Xanthus Pharmaceuticals, Inc.INDUSTRY | 2 | Feb 19, 2007 | clinicaltrials |
| NCT00415285 | Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer | unknown | Phase 2 | 100 | Georgia Center for Oncology Research & EducationOTHER | 1 | Feb 13, 2007 | clinicaltrials |
| NCT00055250 | A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer | completed | Phase 2 | 130 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00061464 | Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials